.png){kind=icon}
返回
Artificial intelligence in virtual screening: Models versus experiments
.png){kind=icon}
PRE
AI
DOI：10.1016/j.drudis.2022.05.013.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
A typical drug discovery project involves identifying active compounds with significant binding potential for selected disease-specific targets. Experimental high-throughput screening (HTS) is a traditional approach to drug discovery, but is expensive and time-consuming when dealing with huge chemical libraries with billions of compounds. The search space can be narrowed down with the use of reliable computational screening approaches. In this review, we focus on various machine-learning (ML) and deep-learning (DL)-based scoring functions developed for solving classification and ranking problems in drug discovery. We highlight studies in which ML and DL models were successfully deployed to identify lead compounds for which the experimental validations are available from bioassay studies.
Keyword:
Computational drug discovery
Scoring functions
Machine learning-based scoring
Binding affinity
Binding assay studies
Chemical spaces
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
引用论文
Fabrication and compatibility evaluation of polycaprolactone/hydroxyapatite/collagen-based fiber scaffold for anterior cruciate ligament injury.png)
RSC Advances
OAAI
RSC AdvancesIF0
OAAI分享收藏SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machinesSimBoost: 一种使用梯度增强机器预测药物-靶标结合亲和力的跨读方法
OAAI
OAAI分享收藏
查看更多内容